Southern Brazilian autumnal propolis shows anti-angiogenic activity: An in vitro and in vivo study

Microvascular Research

Volumn 88, Issue , 2013, Pages 1-11

  Meneghelli, Cristiane ^a   Joaquim, Lisiê Silva Dalsasso ^a   Félix, Giovanni Loos Queiroz ^a   Somensi, Amélia ^a   Tomazzoli, Maíra ^a   da Silva, Diego Adílio ^a   Berti, Fernanda Vieira ^a   Veleirinho, Maria Beatriz Rocha ^a   Recouvreux, Derce de Oliveira Souza ^a   de Mattos Zeri, Ana Carolina ^b   Dias, Paulo Fernando ^a   Maraschin, Marcelo ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b BRAZILIAN CENTER FOR RESEARCH IN ENERGY AND MATERIALS CNPEM   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROGENIC ACID; FLAVONOID; GALLIC ACID; INDOMETACIN; PHENOL DERIVATIVE; PROPOLIS; PROTOCATECHUIC ACID; QUERCETIN; ANGIOGENESIS INHIBITOR; COLLAGEN; DRUG COMBINATION; FLAVONE DERIVATIVE; HYDROXYBENZOIC ACID DERIVATIVE; LAMININ; MATRIGEL; PHENOL; PHENOLIC ACID; PROTEOGLYCAN;

ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BRAZIL; CELL VIABILITY; CHEMICAL COMPOSITION; CHICK EMBRYO; CHORIOALLANTOIS; CONTROLLED STUDY; DRUG CYTOTOXICITY; EMBRYO; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MIGRATION INHIBITION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRAVIOLET SPECTROPHOTOMETRY; UMBILICAL VEIN ENDOTHELIAL CELL; VITELLINE MEMBRANE; ANGIOGENESIS; ANIMAL; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; DRUG COMBINATION; DRUG EFFECTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SEASON; TIME;

ANGIOGENESIS INHIBITORS; ANIMALS; BRAZIL; CELL PROLIFERATION; CELL SURVIVAL; CHICK EMBRYO; CHLOROGENIC ACID; CHORIOALLANTOIC MEMBRANE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLLAGEN; DRUG COMBINATIONS; FLAVONES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYDROXYBENZOATES; LAMININ; MAGNETIC RESONANCE SPECTROSCOPY; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOL; PROPOLIS; PROTEOGLYCANS; SEASONS; SPECTROPHOTOMETRY, ULTRAVIOLET; TIME FACTORS;

EID: 84878604056     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2013.03.003     Document Type: Article

References (68)

1. Ahn M.R., Kunimasa K., Ohta T., Kumazawa S., Kamihira M., Kaji K., Uto Y., Hori H., Nagasawa H., Nakayama T. Suppression of tumor-induced angiogenesis by Brazilian propolis: major component artepillin C inhibits in vitro tube formation and endothelial cell proliferation. Cancer Lett. 2007, 252:235-243.
2. Ahn M.R., Kunimasa K., Kumazawa S., Nakayama T., Kaji K., Uto Y., Hori H., Nagasawa H., Ohta T. Correlation between antiangiogenic activity and antioxidant activity of various components of propolis. Mol. Nutr. Food Res. 2009, 53:643-651.
3. Banskota A.H., Tezuka Y., Kadota S. Recent progress in pharmacological research of propolis. Phytother. Res. 2001, 15:561-571.
4. Basini G., Baioni L., Bussolati S., Grasselli F., Daquino C., Spatafora C., Tringali C. Antiangiogenic properties of an unusual benzo[k, l]xanthene lignin derived from CAPE (caffeic acid phenethyl ester). Invest. New Drugs 2010, 30:186-190.
5. Bertelli D., Papotti G., Bortolotti L., Marcazzanb G.L., Plessia M. 1H-NMR simultaneous identification of health-relevant compounds in propolis extracts. Phytoche. Anal. 2011, 23:260-266.
6. Carmeliet P. Angiogenesis in health and diseases. Nat. Med. 2003, 9:653-660.
7. Castaldo S., Capasso F. Propolis, an old remedy used in modern medicine. Fitoterapia 2002, 73(Suppl. 1):1-6.
8. Castro S.L. Propolis: biological and pharmacological activities. Therapeutic uses of this bee-product. Annu. Rev. Biomed. Sci. 2001, 3:49-83.
9. Chikaraishi Y., Izuta H., Shimazawa M., Mishima S., Hara H. Angiostatic effects of Brazilian green propolis and its chemical constituents. Mol. Nutr. Food Res. 2010, 54:566-575.
10. Chung A.S., Ferrara N. The extracellular matrix & angiogenesis: role of the extracellular matrix in developing vessels and tumor angiogenesis. Pathways. 2010, 11:2-5.
11. Daleprane J.B., Schmid T., Dehne N., Rudnicki M., Menrad H., Geis T., Ikegaki M., Ong T.P., Brune B., Abdalla D.S.P. Suppression of hypoxia-inducible factor-1α contributes to the antiangiogenic activity of red propolis polyphenols in human endothelial cells. J. Nutr. 2012, 142:441-447.
12. Daugsch A., Moraes C.S., Fort P., Park Y.K. Brazilian red propolis - chemical composition and botanical origin. Evid. Based Complement. Alternat. Med. 2007, 5:435-441.
13. Dias P.F., Siqueira JR J.M., Vendruscolo L.F., Neiva T.J., Gagliardi A.R., Maraschin M., Ribeiro-do-Valle R.M. Antiangiogenic and antitumoral properties of a polysaccharide isolated from the seaweed Sargassum stenophyllum. Cancer Chemother. Pharmacol. 2005, 56:436-446.
14. Dias P.F., Berti F.V., Siqueira JR J.M., Maraschin M., Gagliardi A.R., Ribeiro-do-Valle R.M. Trans-resveratrol inhibits early blood vessel formation (vasculogenesis) without impairment of embryonic growth. J. Pharmacol. Sci. 2008, 107:118-127.
15. Dias P.F., Siqueira JR J.M., Maraschin M., Ferreira A.G., Gagliardi A.R., Ribeiro-do-Valle R.M. A polysaccharide isolated from the brown seaweed Sargassum stenophyllum exerts antivasculogenic effects evidenced by modified morphogenesis. Microvas. Res. 2008, 75:34-44.
16. Dong L.F., Swettenham E., Eliasson J., Wang X.F., Gold M., Medunic Y., Stantic M., Low P., Prochazka L., Witting P.K., Turanek J., Akporiaye E.T., Ralph S.J., Neuzil J. Vitamin E analogues inhibit angiogenesis by selective induction of apoptosis in proliferating endothelial cells: the role of oxidative stress. Cancer Res. 2007, 67:11906-11913.
17. Dota K.F.D., Consolaro M.E.L., Svidzinski T.I.E., Bruschi M.L. Antifungal activity of Brazilian propolis microparticles against yeasts isolated from vulvovaginal candidiasis. Evid. Based Complement. Alternat. Med. 2010, 2011:1-8.
18. Ellis L.M., Hicklin D.L. VEGF-targeted therapy: mechanisms of anti-tumour activity. Nat. Rev. Cancer 2008, 8:579-591.
19. Evciment N.D., King G.L. The role of protein kinase C activation and the vascular complications of diabetes. Pharmacol. Res. 2007, 55:498-510.
20. Fan T.W.M. Metabolite profiling by one- and two-dimensional NMR analysis of complex mixtures. Prog. Nucl. Mag. Res. Sp. 1996, 28:161-219.
21. Fan T.W.M., Lane A. Structure-based profiling of metabolites and isotopomers by NMR. Prog. Nucl. Mag. Res. Sp. 2008, 52:69-117.
22. Folkman J. Is angiogenesis an organizing principle in biology and medicine?. J. Pediatr. Surg. 2007, 42:1-11.
23. Goodwin A.M. In vitro assays of angiogenesis for assessment of angiogenic and anti-angiogenic agents. Microvas. Res. 2007, 74:172-183.
24. Hepsen I.F., Er H., Cekiç O. Topically applied water extract of propolis to suppress corneal neovascularization in rabbits. Ophthalmic Res. 1999, 31:426-431.
25. Hu F., Hepburn H.R., Li Y., Chen M., Radloff S.E., Daya S. Effects of ethanol and water extracts of propolis (bee glue) on acute inflammatory animal models. J. Ethnopharmacol. 2005, 100:276-283.
26. Igura K., Ohta T., Kuroda Y., Kaji K. Resveratrol and quercetin inhibit angiogenesis in vitro. Cancer Lett. 2001, 28:11-16.
27. Izuta H., Shimazawa M., Tsuruma K., Akaki Y., Mishima S., Hara H. Bee products prevent VEGF-induced angiogenesis in human umbilical vein endothelial cells. Evid. Based Complement. Alternat. Med. 2009, 9:1-10.
28. Jakob W., Jentzsch K.D., Mauersberger B., Heder G. The chick embryo chorioallantoic membrane as a bioassay for angiogenesis actors: reactions induced by carrier materials. Exp. Pathol. 1978, 15:241-249.
29. Jan G., Gyllenhaal C., Soerjato D.D. Biodiversity as a source of anticancer drugs. Curr. Drug Targets. 2006, 7:265-277.
30. Jeon H., Kim H., Choi D., Kim D., Park S.Y., Kim Y.J., Kim Y.M., Jung Y. Quercetin activates an angiogenic pathway, hypoxia inducible factor (HIF)-1-vascular endothelial growth factor, by inhibiting HIF-prolyl hydroxylase: a structural analysis of quercetin for inhibiting HIF-prolyl hydroxylase. Mol. Pharmacol. 2007, 71:1676-1684.
31. Kosalec I., Bakmaz M., Pepeljnjak S., Vladimir-Knezevi S. Quantitative analysis of the flavonoids in raw propolis from northern Croatia. Acta Pharm. 2004, 54:65-72.
32. Kuhnen S., Ogliari J.B., Dias P.F., Santos M.S., Ferreira A.G., Bonham C.C., Wood K.V., Maraschin M. Metabolic fingerprint of Brazilian maize landraces silk (stigma/styles) using NMR spectroscopy and chemometric methods. J. Agric. Food Chem. 2010, 58:2194-2200.
33. Kumazawa S., Hamasaka T., Nakayama T. Antioxidant activity of propolis of various geographic origins. Food Chem. 2004, 84:329-339.
34. Kunimasa K., Ahn M.R., Kobayashi T., Eguchi R., Kumazawa S., Fujimori Y., Nakano T., Nakayama T., Kaji K., Ohta T. Brazilian propolis suppresses angiogenesis by inducing apoptosis in tube-forming endothelial cells through inactivation of survival signal ERK1/2. Evid. Based Complement. Alternat. Med. 2009, 2011:1-8.
35. Liao H.F., Chen Y.Y., Liu J.J., Hsu M.L., Shieh H.J., Liao H.J., Shieh C.J., Shiao M.S., Chen Y.J. Inhibitory effect of caffeic acid phenethyl ester on angiogenesis, tumor invasion, and metastasis. J. Agric. Food Chem. 2003, 51:7907-7912.
36. Lofty M. Biological activity of bee propolis in health and disease. Asian Pac. J. Cancer Prev. 2006, 7:22-31.
37. Lopes F.C.M., Rocha A., Pirraco A., Regasini L.O., Silva D.H.S., Bolzani V.S., Azevedo I., Carlos I.Z., Soares R. Anti-angiogenic effects of pterogynidine alkaloid isolated from Alchornea glandulosa. BMC Complement. Alternat. Med. 2009, 22:9-15.
38. Maharaj A.S., D'Amore P.A. Roles for VEGF in the adult. Microvas. Res. 2007, 74:100-113.
39. Marcucci M.C., Ferreres F., García-Viguera C., Bankova V.S., De Castro S.L., Dantas A.P., Valente P.H.M., Paulino N. Phenolic compounds from Brazilian propolis with pharmacological activities. J. Ethnopharmacology. 2001, 74:105-112.
40. Martos M.V., Ruiz-Navajas Y., Fernández-Lópes J., Pérez-Álvarez J.A. Functional properties of honey, propolis and royal jelly. J. Food Sci. 2008, 73:117-124.
41. Messerli S.M., Ahn M.R., Kunimasa K., Yanagihara M., Tatefuji T., Hashimoto K., Mautner V., Uto Y., Hori H., Kumazawa S., Kaji K., Ohta T., Maruta H. Artepillin C (ARC) in Brazilian green propolis selectively blocks oncogenic PAK1signaling and suppresses the growth of NF tumors in mice. Phytother. Res. 2009, 23:423-427.
42. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
43. Moura S.A.L., Ferreira M.A.N.D., Andrade S.P., Reis M.L.C., Noviello M.L., Cara D.C. Brazilian green propolis inhibits inflammatory angiogenesis in a murine sponge model. Evid. Based Complement. Alternat. Med. 2009, 9:1-7.
44. Nguyen M., Shing Y., Folkman J. Quantitation of angiogenesis and antiangiogenesis. In the chick embryo chorioallantoic membrane. Microvas. Res. 1994, 47:31-40.
45. Ohta T., Kunimasa K., Kobayashi T., Sakaoto M., Kaji K. Propolis suppresses tumor angiogenesis by inducing apoptosis in tube-forming endothelial cells. Biosci. Biotechnol. Biochem. 2008, 72:2436-2440.
46. Otrock Z.K., Mahfouz R.A.R., Makarem J.A., Shamseddine A.I. Understanding the biology of angiogenesis: review of the most important molecular mechanisms. Blood Cells Mol. Dis. 2007, 39:212-220.
47. Pereira A.A., Seixas F.R.M.S., Neto F.R.A. Própolis: 100 anos de pesquisa e suas perspectivas futuras. Quím. Nova 2002, 5:321-326.
48. Phillips G.D., Whitehead R.A., Knighton D.R. Initiation and pattern of angiogenesis in wound healing in the rat. Am. J. Anat. 1991, 192:257-262.
49. Pober J.S., Sessa W.C. Evolving functions of endothelial cells in inflammation. Nat. Rev. Immunol. 2007, 7:803-815.
50. Pober J.S., Lapierre L.A., Stolpen A.H., Brock T.A., Springer T.A., Fiers W., Bevilacqua M.P., Mendrick D.L., Gimbrone M.A. Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species. J. Immunol. 1987, 138:3319-3324.
51. Popova M., Bankova V., Butovska D., Petkov V., Nikolova-Damyanova B., Sabatini A.G., Marcazzan G.L., Bogdanov S. Validated methods for the quantification of biologically active constituents of poplar type-propolis. Phytochem. Anal. 2007, 15:235-240.
52. Risau W. Mechanisms of angiogenesis. Nature 1997, 386:671-674.
53. Rossi A., Longo R., Russo A., Borelli F., Sautebin L. The role of the phenethyl ester of caffeic acid (CAPE) in the inhibition of rat lung cyclooxygenase. Fitoterapia 2002, 73:30-37.
54. Sahinler N., Kaftanoglu O. Natural product propolis: chemical composition. Nat. Prod. Res. 2005, 19:183-188.
55. Sforcin J.M. Propolis and the immune system: a review. J. Ethnopharmacol. 2007, 113:1-14.
56. Sforcin J.M., Bankova V. Propolis: is there a potential for the development of new drugs?. J. Ethnopharmacol. 2011, 133:253-260.
57. Shimizu T., Takeshita Y., Takamori Y., Kai H., Sawamura R., Yoshida H., Watanabe W., Tsutsumi A., Park Y.K., Yasukawa K., Matsuno K., Shiraki K., Kurokawa M. Efficacy of Brazilian propolis against herpes simplex virus type 1 infection in mice and their modes of antiherpetic efficacies. Evid. Based Complement. Alternat. Med. 2011, 2011:1-9.
58. Song Y.S., Park E.H., Jung K.J., Jin C. Inhibition of angiogenesis by propolis. Arch. Pharm. Res. 2002, 25:500-504.
59. Tan W., Lin L., Li M., Zhang Y.X., Tong Y., Xiao D., Ding J. Quercetin, a dietary-derived flavonoid, possesses anti-angiogenic potential. Eur. J. Pharmacol. 2003, 459:255-262.
60. Wang D., DuBois R.N. Cyclocygenase 2-derived prostaglandin E2 regulates the angiogenic switch. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:415-416.
61. Waterman P.G., Mole S. Analysis of Phenolic Plant Metabolites 1994, Blackwell Scientific Publications, London.
62. Wu J., Omene C., Karkoszka J., Bosland M., Eckard J., Klein C.B., Frenkel K. Caffeic acid phenethyl ester (CAPE), derived from a honeybee product propolis, exhibits a diversity of anti-tumor effects in pre-clinical models of human breast cancer. Cancer Lett. 2011, 308:43-53.
63. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., Holash J. Vascular specific growth factors and blood vessel formation. Nature 2000, 407:242-248.
64. http://wishart.biology.ualberta.ca/metabominer/index.html.
65. http://mmcd.nmrfam.wisc.edu.
66. http://riodb01.ibase.aist.go.jp/sdbs/cgi-bin/creindex.cgi.
67. http://www.bmrb.wisc.edu/metabolomics/metabolomicsstandards.html.
68. http://www.hmdb.ca.